Veramyst and Naftin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veramyst (fluticasone furoate) and Naftin (naftifine hydrochloride). Common drug interactions include depression among males.

The phase IV clinical study analyzes what interactions people have when they take Veramyst and Naftin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Veramyst?

Veramyst has active ingredients of fluticasone furoate. It is often used in allergies. eHealthMe is studying from 3,444 Veramyst users. Check the latest studies of Veramyst.

What is Naftin?

Naftin has active ingredients of naftifine hydrochloride. eHealthMe is studying from 377 Naftin users. Check the latest studies of Naftin.



On Jul, 11, 2026

14 people who take Veramyst and Naftin together, and have interactions are studied.

Veramyst and Naftin drug interactions.

What are the common drug interactions of Veramyst and Naftin, by gender? *:

female:

n/a

male:

  1. Depression
  2. Hospitalisation
  3. Diarrhoea
  4. Gout (uric acid crystals building up in the body)
  5. Hypersensitivity
  6. Insomnia (sleeplessness)
  7. Oral discomfort (pain or irritation in mouth)
  8. Therapeutic response unexpected
  9. Weight increased
  10. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)

What are the common drug interactions of Veramyst and Naftin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Insomnia (sleeplessness)

30-39:

  1. Ankle fracture
  2. Confusional state
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Lung disorder (lung disease)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Gout (uric acid crystals building up in the body)
  7. Therapeutic response unexpected

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 100.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 78.57%

* Approximation only. Some reports may have incomplete information.

Do you take Veramyst and Naftin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Veramyst and Naftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Veramyst:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veramyst and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naftin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate and naftifine hydrochloride (the active ingredients of Veramyst and Naftin, respectively), and Veramyst and Naftin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: